Checkpoint Therapeutics (CKPT) PT Raised to $20 at Cantor Fitzgerald Following Positive Data
Tweet Send to a Friend
Cantor Fitzgerald analyst Jennifer Kim raised the price target on Checkpoint Therapeutics (NASDAQ: CKPT) to $20.00 (from $16.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
